Mark K. Wedel

2.1k citations

30 papers · 1.6k indexed · h-index 19

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cancer Research top 10%
- Cancer, Lipids, and Metabolism

Papers in

Gastroenterology 2
Anesthesiology and Pain Medicine 2
- Airway Management and Intubation Techniques 2

Co-authors: Brenda F. Baker Rosie Z. Yu Emil Chuang Philip B. Miner John J.P. Kastelein John Q. Su Diane L. Tribble Richard S. Geary
Journals: Alimentary Pharmacology & Therapeutics (4 papers)Alcohol and Alcoholism (3 papers)Atherosclerosis Supplements (3 papers)CHEST Journal (2 papers)Clinical Pharmacokinetics (2 papers)
Partner nations: United States Netherlands Canada

In The Last Decade

Mark K. Wedel

30 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mark K. Wedel

Since Specialization

Citations

This map shows the geographic impact of Mark K. Wedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Wedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Wedel more than expected).

Fields of papers citing papers by Mark K. Wedel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark K. Wedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Wedel. The network helps show where Mark K. Wedel may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark K. Wedel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark K. Wedel Line = papers co-authored together Mark K. Wedel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins Journal of Lipid Research ·Jeremy D. Furtado, Mark K. Wedel, Frank M. Sacks	2012	21
2	Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia European Heart Journal ·Fatima Akdim, Diane L. Tribble, JoAnn Flaim, Rosie Z. Yu, John Q. Su, Richard S. Geary, Brenda F. Baker, Rainard Fuhr, Mark K. Wedel, John J.P. Kastelein	2011	102
3	Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy Journal of the American College of Cardiology ·Fatima Akdim, Erik S.G. Stroes, Eric J.G. Sijbrands, Diane L. Tribble, Mieke D. Trip, J. Wouter Jukema, JoAnn Flaim, John Q. Su, Rosie Z. Yu, Brenda F. Baker, Mark K. Wedel, John J.P. Kastelein	2010	128
4	Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2′-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe Clinical Pharmacokinetics ·Rosie Z. Yu, Richard S. Geary, JoAnn D Flaim, Gina C Riley, Diane L. Tribble, André A vanVliet, Mark K. Wedel	2008	82
5	Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100 Biochemical Pharmacology ·Rosie Z. Yu, Kristina M. Lemonidis, Mark J. Graham, John Matson, Rosanne M. Crooke, Diane L. Tribble, Mark K. Wedel, Arthur A. Levin, Richard S. Geary	2008	96
6	A Randomized, Double-Masked, Placebo-Controlled Study of Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule 1, for the Treatment of Subjects With Active Crohn’s Disease Clinical Gastroenterology and Hepatology ·Bruce Yacyshyn, William Y. Chey, Mark K. Wedel, Rosie Z. Yu, David A. Paul, Emil Chuang	2007	98
7	PO23-746 ISIS 301012, AN ANTISENSE INHIBITOR OF APO B, PRODUCES SIGNIFICANT ADDITIONAL REDUCTION OF LDL-C & APOB IN HYPERCHOLESTEROLEMIC SUBJECTS ON STATINS NOT MEETING TARGET Atherosclerosis Supplements ·JohnJ.P. Kastelein, Fatima Akdim, Mieke D. Trip, Eric J.G. Sijbrands, F. Jukema, Frank L.J. Visseren, J.D. Bradley, Mark K. Wedel, Jinglan Su, Emil Chuang, Diane L. Tribble, Evan A. Stein	2007	5
8	Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis Alimentary Pharmacology & Therapeutics ·Philip B. Miner, Richard S. Geary, John Matson, Emil Chuang, S. Xia, Brenda F. Baker, Mark K. Wedel	2006	39
9	Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial Alimentary Pharmacology & Therapeutics ·Philip B. Miner, Mark K. Wedel, S. Xia, Brenda F. Baker	2006	74
10	Lack of Pharmacokinetic Interaction for ISIS 113715, a 2???-0-Methoxyethyl Modified Antisense Oligonucleotide Targeting Protein Tyrosine Phosphatase 1B Messenger RNA, with Oral Antidiabetic Compounds Metformin, Glipizide or Rosiglitazone Clinical Pharmacokinetics ·Richard S. Geary, JoAnn D. Bradley, Tanya Watanabe, Younggil Kwon, Mark K. Wedel, Jan Jaap van Lier, Andr A vanVliet	2006	39
11	A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis Alimentary Pharmacology & Therapeutics ·Sander J. H. van Deventer, Mark K. Wedel, Brenda F. Baker, S. Xia, Emil Chuang, Philip B. Miner	2006	89
12	Partial Liquid Ventilation in Adult Patients with Acute Respiratory Distress Syndrome American Journal of Respiratory and Critical Care Medicine ·Robert M. Kacmarek, Herbert Wiedemann, Philip T. Lavin, Mark K. Wedel, Ahmet Tütüncü, Arthur S. Slutsky	2005	111
13	An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule‐1, in the treatment of chronic, unremitting pouchitis Alimentary Pharmacology & Therapeutics ·Philip B. Miner, Mark K. Wedel, Barbara L. Bane, J. Andrew Bradley	2004	111
14	Clinical Correlation With Changing Radiographic Appearance During Partial Liquid Ventilation CHEST Journal ·Daniel P. Schuster, Neale Lange, Ahmet Tütüncü, Mark K. Wedel	2001	6
15	Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men British Journal Of Nutrition ·H. W. van der Torre, W. van Dokkum, G. Schaafsma, Mark K. Wedel, T Ockhuizen	1991	61
16	APPLICATION OF A THREE-COMPARTMENT MODEL TO A STUDY OF THE EFFECTS OF SEX, ALCOHOL DOSE AND CONCENTRATION, EXERCISE AND FOOD CONSUMPTION ON THE PHARMACOKINETICS OF ETHANOL IN HEALTHY VOLUNTEERS Alcohol and Alcoholism ·Mark K. Wedel, Jürgen Pieters, N. A. Pikaar, Th. Ockhuizen	1991	37
17	PARAMETER ESTIMATION IN A THREE-COMPARTMENT MODEL FOR BLOOD ALCOHOL CURVES Alcohol and Alcoholism ·Jürgen Pieters, Mark K. Wedel, G. Schaafsma	1990	14
18	Effects of a moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state. PubMed ·Jan A. Veenstra, T Ockhuizen, H. van de Pol, Mark K. Wedel, G. Schaafsma	1990	52
19	Comparison of ultrasound and skinfold caliper measurement of subcutaneous fat tissue. PubMed ·T Weits, van der Beek Ej, Mark K. Wedel	1986	33
20	Platelet kinetics in venovenous membrane oxygenation. PubMed ·Roger G. Spragg, Richard N. Hill, Mark K. Wedel, A Materson, Katrin Moser	1975	9

About Mark K. Wedel

Mark K. Wedel is a scholar working on Gastroenterology, Anesthesiology and Pain Medicine, Immunology and Allergy, Internal Medicine and Surgery, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Inflammatory Bowel Disease (5 papers), Alcohol Consumption and Health Effects (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Airway Management and Intubation Techniques (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (269 citations), Cancer Research (199 citations), Surgery (537 citations), Genetics (334 citations) and Immunology and Allergy (64 citations). Mark K. Wedel has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Brenda F. Baker, Rosie Z. Yu, Emil Chuang, Philip B. Miner, John J.P. Kastelein, John Q. Su, Diane L. Tribble, Richard S. Geary, Mark J. Graham and Rosanne M. Crooke. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Alcohol and Alcoholism, Atherosclerosis Supplements, CHEST Journal and Clinical Pharmacokinetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact